Actionable news
0
All posts from Actionable news
Actionable news in RVNC: REVANCE THERAPEUTICS Inc,

Revance Therapeutics just filed a prospectus, suggesting it plans to soon issue some securities

Revance Therapeutics just came out with a new prospectus, available here. This is an SEC requirement for firms looking to issue certain types of securities. An excerpt of the prospectus is provided below:

We estimate that the net proceeds from the sale of shares of our common stock in this offering will be $119.1 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. If the underwriters option to purchase additional shares in this offering is exercised in full, we estimate that our net proceeds would be $137.1 million, after deducting underwriting discounts and commissions and estima ted offering expenses payable by us.

We currently expect to use the net proceeds...


More